Healx (healx.io), today announced a partnership with Boston Children’s Hospital and Barth Syndrome Foundation (BSF) to advance promising therapeutic compounds using a novel approach that will accelerate drug discovery for applications in Barth syndrome
Read the latest news about Healx and our goal to advance treatments for rare diseases.
Kate has extensive expertise in drug discovery and her appointment underlines our mission to combine deep pharmacological expertise with Artificial Intelligence
We are delighted to announce $10 million Series A funding round, led by Balderton Capital. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
The Business Weekly article also covers the appointment of Shaun Grady, a leading business development executive at Astra Zeneca, to Healx’s board of directors
Erin Oerton, a PhD student at the University of Cambridge and data scientist at Healx, has won the poster prize for the Systems Medicine track at the 2nd Interdisciplinary Signalling Workshop in Visegrad, Hungary.